Precigen (PGEN) Receivables - Net (2012 - 2026)
Precigen (PGEN) posted quarterly Receivables - Net of $26.4 million for Q1 2026, up 3415.71% year-over-year from $751000.0 in Q1 2025, and up 574.23% quarter-over-quarter from $3.9 million in Q4 2025.
Analysis
Precigen (PGEN) Receivables - Net (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Receivables - Net for 15 consecutive years, with $26.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net rose 3415.71% year-over-year to $26.4 million; the TTM figure through Mar 2026 stood at $26.4 million (up 3415.71% YoY), while the FY2025 annual figure was $3.9 million, up 322.89% from the prior year.
- Receivables - Net rose to $26.4 million in Q1 2026 per PGEN's latest filing, from $3.9 million in the prior quarter.
- Across five years, Receivables - Net topped out at $26.4 million in Q1 2026 and bottomed at $327000.0 in Q2 2025.
- Historically, Receivables - Net has averaged $4.0 million across 5 years, with a median of $978000.0 in 2022.
- Annual changes were most pronounced in 2022 — Receivables - Net sank 94.98% — and 2026, when it jumped 3415.71%.
- Precigen's Receivables - Net stood at $978000.0 in 2022, then fell by 7.77% to $902000.0 in 2023, then rose by 2.66% to $926000.0 in 2024, then surged by 322.89% to $3.9 million in 2025, then surged by 574.23% to $26.4 million in 2026.
- Business Quant data shows PGEN's Receivables - Net at $26.4 million in Q1 2026, $3.9 million in Q4 2025, and $580000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71.87 Mn |
| Mar 31, 2026 | 26.40 Mn |
| Dec 31, 2025 | 3.92 Mn |
| Sep 30, 2025 | 580,000.00 |
| Jun 30, 2025 | 327,000.00 |
| Mar 31, 2025 | 751,000.00 |
| Dec 31, 2024 | 926,000.00 |
| Sep 30, 2024 | 479,000.00 |
| Jun 30, 2024 | 511,000.00 |
| Mar 31, 2024 | 872,000.00 |
| Dec 31, 2023 | 902,000.00 |
| Sep 30, 2023 | 988,000.00 |
| Jun 30, 2023 | 1.35 Mn |
| Mar 31, 2023 | 1.77 Mn |
| Dec 31, 2022 | 978,000.00 |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 24.31 Mn |
| Dec 31, 2021 | 1.34 Mn |
| Sep 30, 2021 | 20.17 Mn |